{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:38:06Z","timestamp":1792719486431,"version":"4.5.0"},"reference-count":191,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"DOI":"10.1007\/s10787-026-02433-w","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:02:46Z","timestamp":1792717366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut\u2013brain axis in Alzheimer\u2019s disease: neuroinflammatory mechanisms and immunopharmacological interventions"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4015-7968","authenticated-orcid":false,"given":"Rishab","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6320-3951","authenticated-orcid":false,"given":"Gaurav","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1673-9985","authenticated-orcid":false,"given":"Abhay","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"2433_CR1","doi-asserted-by":"publisher","unstructured":"Abdelhamid M, Zhou C, Jung CG, Michikawa M (2022) Probiotic bifidobacterium breve MCC1274 mitigates Alzheimer\u2019s disease-related pathologies in wild-type mice. Nutrients 14(12):2543. https:\/\/doi.org\/10.3390\/nu14122543","DOI":"10.3390\/nu14122543"},{"key":"2433_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fnagi.2016.00256","volume":"8","author":"E Akbari","year":"2016","unstructured":"Akbari E, Asemi Z, Daneshvar Kakhaki R, Bahmani F, Kouchaki E, Tamtaji OR, Hamidi GA, Salami M (2016) Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer\u2019s disease: A randomized, double-blind and controlled trial. Front Aging Neurosci 8:256. https:\/\/doi.org\/10.3389\/fnagi.2016.00256","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"2433_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1080\/17425247.2025.2502022","volume":"22","author":"M Akhtar","year":"2025","unstructured":"Akhtar M, Nehal N, Gull A, Parveen R, Khan S, Khan S, Ali J (2025) Explicating the transformative role of artificial intelligence in designing targeted nanomedicine. Expert Opin Drug Deliv 22(7):971\u2013991. https:\/\/doi.org\/10.1080\/17425247.2025.2502022","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"2433_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1159\/000548021","volume":"32","author":"KM Aleman-Villa","year":"2025","unstructured":"Aleman-Villa KM, Armienta-Rojas DA, Camberos-Barraza J, Rabago-Monzon AR, Camacho-Zamora A, Osuna-Ramos JF, Magana-Gomez JA, Guadron-Llanos AM, Calderon-Zamora L, Norzagaray-Valenzuela CD, Valdez-Flores MA, Picos-Cardenas VJ (2025) Neuroinflammation across the spectrum of neurodegenerative diseases: mechanisms and therapeutic frontiers. Neuroimmunomodulation 32(1):278\u2013305. https:\/\/doi.org\/10.1159\/000548021","journal-title":"Neuroimmunomodulation"},{"issue":"22","key":"2433_CR5","doi-asserted-by":"publisher","first-page":"10959","DOI":"10.3390\/ijms262210959","volume":"26","author":"C Alius","year":"2025","unstructured":"Alius C, Breazu A, Pantu C, Toader C, Serban M, Covache-Busuioc RA, Munteanu O, Dumitru AV (2025) The endocannabinoid-microbiota-neuroimmune super-system: a unifying feedback architecture for systems resilience, collapse trajectories, and precision feedback medicine. Int J Mol Sci 26(22):10959. https:\/\/doi.org\/10.3390\/ijms262210959","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2433_CR6","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.clnu.2022.09.012","volume":"41","author":"MR Aljumaah","year":"2022","unstructured":"Aljumaah MR, Bhatia U, Roach J, Gunstad J, Azcarate Peril MA (2022) The gut microbiome, mild cognitive impairment, and probiotics: a randomized clinical trial in middle-aged and older adults. Clin Nutr 41(11):2565\u20132576. https:\/\/doi.org\/10.1016\/j.clnu.2022.09.012","journal-title":"Clin Nutr"},{"key":"2433_CR7","unstructured":"Arbib MA, Szent\u00e1gothai J (1998) Neural organization: structure, function, and dynamics. MIT Press"},{"issue":"3","key":"2433_CR8","doi-asserted-by":"publisher","first-page":"e200621","DOI":"10.1212\/CPJ.0000000000200621","volume":"16","author":"A Atri","year":"2026","unstructured":"Atri A, Apostolova LG, Iwata A, Wessels AM, Atkins A, Lu M, Ye W, Ryan S, Doty EG (2026) Clinical meaningfulness of Donanemab in early symptomatic alzheimer disease: data from the randomized phase 3 TRAILBLAZER-ALZ 2 Trial. Neurol Clin Pract 16(3):e200621. https:\/\/doi.org\/10.1212\/CPJ.0000000000200621","journal-title":"Neurol Clin Pract"},{"issue":"10","key":"2433_CR9","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.1007\/s00210-024-03109-4","volume":"397","author":"N Aziz","year":"2024","unstructured":"Aziz N, Wal P, Patel A, Prajapati H (2024) A comprehensive review on the pharmacological role of gut microbiome in neurodegenerative disorders: potential therapeutic targets. Naunyn Schmiedebergs Arch Pharmacol 397(10):7307\u20137336. https:\/\/doi.org\/10.1007\/s00210-024-03109-4","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"2433_CR10","doi-asserted-by":"publisher","first-page":"10634","DOI":"10.1038\/s41467-024-54779-w","volume":"15","author":"N Baligacs","year":"2024","unstructured":"Baligacs N, Albertini G, Borrie SC, Serneels L, Pridans C, Balusu S, De Strooper B (2024) Homeostatic microglia initially seed and activated microglia later reshape amyloid plaques in Alzheimer\u2019s Disease. Nat Commun 15(1):10634. https:\/\/doi.org\/10.1038\/s41467-024-54779-w","journal-title":"Nat Commun"},{"issue":"1","key":"2433_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12668-025-02276-9","volume":"16","author":"A Banerjee","year":"2026","unstructured":"Banerjee A, Goswami A, Choudhury A (2026) Convergence in nanomedicine: integrating brain-targeted delivery and gut microbiota modulation for neurological protection. BioNanoScience 16(1):75","journal-title":"BioNanoScience"},{"key":"2433_CR12","unstructured":"Barton JR (2024) Regulation of the gut-brain axis by guanylyl cyclase C. Thomas Jefferson University."},{"issue":"6","key":"2433_CR13","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/s41380-023-02113-z","volume":"28","author":"N Basheer","year":"2023","unstructured":"Basheer N, Smolek T, Hassan I, Liu F, Iqbal K, Zilka N, Novak P (2023) Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer\u2019s disease? From preclinical studies to the clinical trials. Mol Psychiatry 28(6):2197\u20132214","journal-title":"Mol Psychiatry"},{"key":"2433_CR14","doi-asserted-by":"publisher","first-page":"1697200","DOI":"10.3389\/fpsyt.2025.1697200","volume":"16","author":"J Bautista","year":"2025","unstructured":"Bautista J, Hidalgo-Tinoco C, Di Capua Delgado M, Viteri-Recalde J, Guerra-Guerrero A, Lopez-Cortes A (2025) The gut-brain-circadian axis in anxiety and depression: a critical review. Front Psychiatry 16:1697200. https:\/\/doi.org\/10.3389\/fpsyt.2025.1697200","journal-title":"Front Psychiatry"},{"issue":"1","key":"2433_CR15","doi-asserted-by":"publisher","first-page":"2037838","DOI":"10.1155\/2018\/2037838","volume":"2018","author":"JE Belizario","year":"2018","unstructured":"Belizario JE, Faintuch J, Garay-Malpartida M (2018) Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases. Mediators Inflamm 2018(1):2037838. https:\/\/doi.org\/10.1155\/2018\/2037838","journal-title":"Mediators Inflamm"},{"issue":"3\u20134","key":"2433_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0736-5748(94)00061-7","volume":"13","author":"EN Benveniste","year":"1995","unstructured":"Benveniste EN, Tang LP, Law RM (1995) Differential regulation of astrocyte TNF-alpha expression by the cytokines TGF-beta, IL-6 and IL-10. Int J Dev Neurosci 13(3\u20134):341\u2013349. https:\/\/doi.org\/10.1016\/0736-5748(94)00061-7","journal-title":"Int J Dev Neurosci"},{"key":"2433_CR17","doi-asserted-by":"publisher","first-page":"560375","DOI":"10.3389\/fendo.2020.560375","volume":"11","author":"J Berlanga-Acosta","year":"2020","unstructured":"Berlanga-Acosta J, Guill\u00e9n-Nieto G, Rodr\u00edguez-Rodr\u00edguez N, Bringas-Vega ML, Garc\u00eda-del-Barco-Herrera D, Berlanga-Saez JO, Garc\u00eda-Ojalvo A, Vald\u00e9s-Sosa MJ, Vald\u00e9s-Sosa PA (2020) Insulin resistance at the crossroad of Alzheimer disease pathology: a review. Front Endocrinol 11:560375","journal-title":"Front Endocrinol"},{"issue":"10","key":"2433_CR18","doi-asserted-by":"publisher","first-page":"7987","DOI":"10.1007\/s12035-018-0973-4","volume":"55","author":"L Bonfili","year":"2018","unstructured":"Bonfili L, Cecarini V, Cuccioloni M, Angeletti M, Berardi S, Scarpona S, Rossi G, Eleuteri AM (2018) SLAB51 Probiotic Formulation Activates SIRT1 Pathway Promoting Antioxidant and Neuroprotective Effects in an AD Mouse Model. Mol Neurobiol 55(10):7987\u20138000. https:\/\/doi.org\/10.1007\/s12035-018-0973-4","journal-title":"Mol Neurobiol"},{"issue":"4","key":"2433_CR19","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3390\/molecules25040940","volume":"25","author":"L Bresciani","year":"2020","unstructured":"Bresciani L, Favari C, Calani L, Francinelli V, Riva A, Petrangolini G, Allegrini P, Mena P, Del Rio D (2020) The effect of formulation of curcuminoids on their metabolism by human colonic microbiota. Molecules 25(4):940","journal-title":"Molecules"},{"issue":"1","key":"2433_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-024-00722-y","volume":"19","author":"GC Brown","year":"2024","unstructured":"Brown GC, Heneka MT (2024) The endotoxin hypothesis of Alzheimer\u2019s disease. Mol Neurodegener 19(1):30. https:\/\/doi.org\/10.1186\/s13024-024-00722-y","journal-title":"Mol Neurodegener"},{"key":"2433_CR21","doi-asserted-by":"publisher","DOI":"10.4103\/NRR.NRR-D-26-00462","author":"B Bues","year":"2026","unstructured":"Bues B, Sasmita AO, Mao S, Komarek L, O\u2019Mahony K, Burk K (2026) Axonal pathology and impaired axo-glial crosstalk as early drivers of neurodegeneration. Neural Regen Res. https:\/\/doi.org\/10.4103\/NRR.NRR-D-26-00462","journal-title":"Neural Regen Res"},{"issue":"6","key":"2433_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrclinonc.2010.43","volume":"7","author":"M Buyse","year":"2010","unstructured":"Buyse M, Sargent DJ, Grothey A, Matheson A, de Gramont A (2010) Biomarkers and surrogate end points\u2013the challenge of statistical validation. Nat Rev Clin Oncol 7(6):309\u2013317. https:\/\/doi.org\/10.1038\/nrclinonc.2010.43","journal-title":"Nat Rev Clin Oncol"},{"issue":"23","key":"2433_CR23","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.3390\/cells12232669","volume":"12","author":"C Caceres","year":"2023","unstructured":"Caceres C, Heusser B, Garnham A, Moczko E (2023) The major hypotheses of Alzheimer\u2019s disease: related nanotechnology-based approaches for its diagnosis and treatment. Cells 12(23):2669. https:\/\/doi.org\/10.3390\/cells12232669","journal-title":"Cells"},{"key":"2433_CR24","doi-asserted-by":"publisher","first-page":"856376","DOI":"10.3389\/fimmu.2022.856376","volume":"13","author":"Y Cai","year":"2022","unstructured":"Cai Y, Liu J, Wang B, Sun M, Yang H (2022) Microglia in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease and related therapeutic targets. Front Immunol 13:856376. https:\/\/doi.org\/10.3389\/fimmu.2022.856376","journal-title":"Front Immunol"},{"key":"2433_CR25","doi-asserted-by":"publisher","first-page":"106586","DOI":"10.1016\/j.phrs.2022.106586","volume":"187","author":"H Cao","year":"2023","unstructured":"Cao H, Zhu Y, Hu G, Zhang Q, Zheng L (2023) Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis? Pharmacol Res 187:106586. https:\/\/doi.org\/10.1016\/j.phrs.2022.106586","journal-title":"Pharmacol Res"},{"issue":"2","key":"2433_CR26","first-page":"203","volume":"28","author":"M Carabotti","year":"2015","unstructured":"Carabotti M, Scirocco A, Maselli MA, Severi C (2015) The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. annals gastroenterology: Q publication Hellenic Soc Gastroenterol 28(2):203","journal-title":"Annals gastroenterology: Q publication Hellenic Soc Gastroenterol"},{"key":"2433_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","volume":"49","author":"A Cattaneo","year":"2017","unstructured":"Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, Ferrari C, Guerra UP, Paghera B, Muscio C, Bianchetti A, Volta GD, Turla M, Cotelli MS, Gennuso M, Prelle A, Zanetti O, Lussignoli G, Mirabile D, Group I-F (2017) Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging 49:60\u201368. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.08.019","journal-title":"Neurobiol Aging"},{"issue":"1","key":"2433_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13024-023-00595-7","volume":"18","author":"S Chandra","year":"2023","unstructured":"Chandra S, Sisodia SS, Vassar RJ (2023) The gut microbiome in Alzheimer\u2019s disease: what we know and what remains to be explored. Mol neurodegeneration 18(1):9","journal-title":"Mol neurodegeneration"},{"key":"2433_CR31","doi-asserted-by":"publisher","first-page":"942460","DOI":"10.3389\/fcimb.2022.942460","volume":"12","author":"L Chen","year":"2022","unstructured":"Chen L, Xu X, Wu X, Cao H, Li X, Hou Z, Wang B, Liu J, Ji X, Zhang P, Li H (2022) A comparison of the composition and functions of the oral and gut microbiotas in Alzheimer\u2019s patients. Front Cell Infect Microbiol 12:942460. https:\/\/doi.org\/10.3389\/fcimb.2022.942460","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2433_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s43556-025-00307-1","volume":"6","author":"C Chen","year":"2025","unstructured":"Chen C, Wang GQ, Li DD, Zhang F (2025) Microbiota-gut-brain axis in neurodegenerative diseases: molecular mechanisms and therapeutic targets. Mol Biomed 6(1):64. https:\/\/doi.org\/10.1186\/s43556-025-00307-1","journal-title":"Mol Biomed"},{"issue":"2","key":"2433_CR30","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1152\/physiol.00016.2025","volume":"41","author":"J Chen","year":"2026","unstructured":"Chen J, Xu Y, Cao P (2026a) The role of the gut-brain axis in diseases. Physiol (Bethesda) 41(2):0. https:\/\/doi.org\/10.1152\/physiol.00016.2025","journal-title":"Physiol (Bethesda)"},{"issue":"3","key":"2433_CR32","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/antiox15030347","volume":"15","author":"T Chen","year":"2026","unstructured":"Chen T, Chen H, Qiu Y, Liu Y, Xie M, Huang S, Feng K, Zhuang J, Chen L, Chen Y, Li H, Yang M, Yang Z, Zhu H (2026b) Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics for the prevention and management of Alzheimer\u2019s disease: a narrative review. Antioxid (Basel) 15(3):347. https:\/\/doi.org\/10.3390\/antiox15030347","journal-title":"Antioxid (Basel)"},{"issue":"13","key":"2433_CR33","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.3390\/ijms25137006","volume":"25","author":"M Chmielarz","year":"2024","unstructured":"Chmielarz M, Sobieszczanska B, Sroda-Pomianek K (2024) Metabolic endotoxemia: from the gut to neurodegeneration. Int J Mol Sci 25(13):7006. https:\/\/doi.org\/10.3390\/ijms25137006","journal-title":"Int J Mol Sci"},{"key":"2433_CR34","doi-asserted-by":"crossref","unstructured":"Chung MV (2025) Cost-effectiveness of delaying Alzheimer\u2019s disease progression with novel monoclonal antibodies. University of Washington","DOI":"10.1016\/j.jval.2025.04.2132"},{"key":"2433_CR36","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fnins.2020.00444","volume":"14","author":"W Cui","year":"2020","unstructured":"Cui W, Sun C, Ma Y, Wang S, Wang X, Zhang Y (2020) Inhibition of TLR4 induces M2 microglial polarization and provides neuroprotection via the NLRP3 inflammasome in Alzheimer\u2019s disease. front Neurosci 14:444. https:\/\/doi.org\/10.3389\/fnins.2020.00444","journal-title":"Front Neurosci"},{"issue":"10544","key":"2433_CR37","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/S0140-6736(26)00459-9","volume":"407","author":"JL Cummings","year":"2026","unstructured":"Cummings JL, Atri A, Sano M, Zetterberg H, Scheltens P, Knop FK, Johannsen P, Wichmann CA, Abschneider RM, Leon T, Feldman HH (2026) Efficacy and safety of oral semaglutide 14\u00a0mg (flexible dose) in early-stage symptomatic Alzheimer\u2019s disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials. Lancet 407(10544):2167\u20132179. https:\/\/doi.org\/10.1016\/S0140-6736(26)00459-9","journal-title":"Lancet"},{"issue":"1","key":"2433_CR38","doi-asserted-by":"publisher","first-page":"2206504","DOI":"10.1080\/19490976.2023.2206504","volume":"15","author":"TK Das","year":"2023","unstructured":"Das TK, Ganesh BP (2023) Interlink between the gut microbiota and inflammation in the context of oxidative stress in Alzheimer\u2019s disease progression. Gut Microbes 15(1):2206504","journal-title":"Gut Microbes"},{"issue":"s1","key":"2433_CR39","doi-asserted-by":"publisher","first-page":"S317","DOI":"10.3233\/JAD-240069","volume":"101","author":"SM de la Monte","year":"2024","unstructured":"de la Monte SM (2024) Conquering insulin network dysfunctions in Alzheimer\u2019s disease: Where are we today? J Alzheimer\u2019s Disease 101(s1):S317\u2013S343","journal-title":"J Alzheimer\u2019s Disease"},{"key":"2433_CR40","unstructured":"Degen C (2016) Given and acquired risk factors in cognitive decline, the development of mild cognitive impairment, and Alzheimer\u2019s disease: results of a prospective, population-based, longitudinal study"},{"issue":"9","key":"2433_CR41","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.4103\/NRR.NRR-D-25-00927","volume":"21","author":"T Dong","year":"2026","unstructured":"Dong T, Zhang T, Wang H, Zhang J, Abdullah R, Sun B, Peng G (2026) Microbiota-gut-brain axis and bile acids-driven neuromodulation. Neural Regen Res 21(9):4122\u20134134. https:\/\/doi.org\/10.4103\/NRR.NRR-D-25-00927","journal-title":"Neural Regen Res"},{"issue":"1","key":"2433_CR42","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41591-025-04106-7","volume":"32","author":"P Edison","year":"2026","unstructured":"Edison P, Femminella GD, Ritchie C, Nowell J, Holmes C, Walker Z, Ridha B, Raza S, Livingston NR, Frangou E, Love S, Williams G, Lawrence R, McFarlane B, Archer H, Coulthard E, Underwood BR, Koranteng P, Karim S, Ballard C (2026) Liraglutide in mild to moderate Alzheimer\u2019s disease: a phase 2b clinical trial. Nat Med 32(1):353\u2013361. https:\/\/doi.org\/10.1038\/s41591-025-04106-7","journal-title":"Nat Med"},{"key":"2433_CR43","doi-asserted-by":"publisher","first-page":"1603018","DOI":"10.3389\/fimmu.2025.1603018","volume":"16","author":"MT El-Saadony","year":"2025","unstructured":"El-Saadony MT, Saad AM, Mohammed DM, Alkafaas SS, Ghosh S, Negm SH, Salem HM, Fahmy MA, Mosa WFA, Ibrahim EH, AbuQamar SF, El-Tarabily KA (2025) Curcumin, an active component of turmeric: biological activities, nutritional aspects, immunological, bioavailability, and human health benefits - a comprehensive review. Front Immunol 16:1603018. https:\/\/doi.org\/10.3389\/fimmu.2025.1603018","journal-title":"Front Immunol"},{"key":"2433_CR44","unstructured":"Elzinga J (2023) Microbes, models and mucins: modelling host-microbe Interactions at the Intestinal mucus layer in vitro. Wageningen University and Research]"},{"key":"2433_CR45","doi-asserted-by":"crossref","unstructured":"Espay A, Stecher B (2020) Brain fables: the hidden history of neurodegenerative diseases and a blueprint to conquer them. Cambridge University Press","DOI":"10.1017\/9781108888202"},{"key":"2433_CR46","doi-asserted-by":"publisher","first-page":"1249320","DOI":"10.3389\/fnmol.2023.1249320","volume":"16","author":"J Eugen\u00edn","year":"2023","unstructured":"Eugen\u00edn J, Eugen\u00edn-von Bernhardi L, von Bernhardi R (2023) Age-dependent changes on fractalkine forms and their contribution to neurodegenerative diseases. Front Mol Neurosci 16:1249320","journal-title":"Front Mol Neurosci"},{"key":"2433_CR47","doi-asserted-by":"publisher","first-page":"1885281","DOI":"10.3389\/fmicb.2026.1885281","volume":"17","author":"S Feng","year":"2026","unstructured":"Feng S, Si X, Lu C, Gao Z, Wang J, Yang Q, Lu S, Su T, Yang J, He X, Wu L (2026) Washed microbiota transplantation improves clinical symptoms, gut microbiota, and metabolic profiles in autism spectrum disorder in a twin cohort. Front Microbiol 17:1885281. https:\/\/doi.org\/10.3389\/fmicb.2026.1885281","journal-title":"Front Microbiol"},{"issue":"2","key":"2433_CR48","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/pharmaceutics13020144","volume":"13","author":"EM Fock","year":"2021","unstructured":"Fock EM, Parnova RG (2021) Protective effect of mitochondria-targeted antioxidants against inflammatory response to lipopolysaccharide challenge: a review. Pharmaceutics 13(2):144. https:\/\/doi.org\/10.3390\/pharmaceutics13020144","journal-title":"Pharmaceutics"},{"key":"2433_CR49","doi-asserted-by":"publisher","first-page":"1305933","DOI":"10.3389\/fimmu.2023.1305933","volume":"14","author":"L Fornari Laurindo","year":"2023","unstructured":"Fornari Laurindo L, Aparecido Dias J, Cressoni Araujo A, Torres Pomini K, Machado Galhardi C, Rucco Penteado Detregiachi C, Santos de Argollo Haber L, Donizeti Roque D, Dib Bechara M, Vialogo Marques de Castro M, de Souza Bastos Mazuqueli Pereira E, Jose Tofano R, Jasmin Santos German Borgo I, Maria Barbalho S (2023) Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression. Front Immunol 14:1305933. https:\/\/doi.org\/10.3389\/fimmu.2023.1305933","journal-title":"Front Immunol"},{"issue":"2","key":"2433_CR50","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JAD-142841","volume":"45","author":"RP Friedland","year":"2015","unstructured":"Friedland RP (2015) Mechanisms of molecular mimicry involving the microbiota in neurodegeneration. J Alzheimers Dis 45(2):349\u2013362. https:\/\/doi.org\/10.3233\/JAD-142841","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"2433_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2217\/bmm.09.89","volume":"4","author":"D Galasko","year":"2010","unstructured":"Galasko D, Montine TJ (2010) Biomarkers of oxidative damage and inflammation in Alzheimer\u2019s disease. Biomark Med 4(1):27\u201336. https:\/\/doi.org\/10.2217\/bmm.09.89","journal-title":"Biomark Med"},{"issue":"19","key":"2433_CR52","doi-asserted-by":"publisher","first-page":"8642","DOI":"10.18632\/aging.102352","volume":"11","author":"Q Gao","year":"2019","unstructured":"Gao Q, Wang Y, Wang X, Fu S, Zhang X, Wang RT, Zhang X (2019) Decreased levels of circulating trimethylamine N-oxide alleviate cognitive and pathological deterioration in transgenic mice: a potential therapeutic approach for Alzheimer\u2019s disease. Aging 11(19):8642\u20138663. https:\/\/doi.org\/10.18632\/aging.102352","journal-title":"Aging"},{"issue":"1","key":"2433_CR53","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/biomedicines14010115","volume":"14","author":"M Garcia-Dominguez","year":"2026","unstructured":"Garcia-Dominguez M (2026) Glial cell dynamics in neuroinflammation: mechanisms, interactions, and therapeutic implications. Biomedicines 14(1):115. https:\/\/doi.org\/10.3390\/biomedicines14010115","journal-title":"Biomedicines"},{"key":"2433_CR54","doi-asserted-by":"publisher","unstructured":"Gershon MD, Margolis KG (2021) The gut, its microbiome, and the brain: connections and communications. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI143768","DOI":"10.1172\/JCI143768"},{"issue":"2","key":"2433_CR55","doi-asserted-by":"publisher","first-page":"bvz039","DOI":"10.1210\/jendso\/bvz039","volume":"4","author":"SS Ghosh","year":"2020","unstructured":"Ghosh SS, Wang J, Yannie PJ, Ghosh S (2020) Intestinal barrier dysfunction, LPS translocation, and disease development. J Endocr Soc 4(2):bvz039. https:\/\/doi.org\/10.1210\/jendso\/bvz039","journal-title":"J Endocr Soc"},{"key":"2433_CR56","doi-asserted-by":"publisher","first-page":"1908574","DOI":"10.3389\/fnagi.2026.1908574","volume":"18","author":"M Gong","year":"2026","unstructured":"Gong M, Lan J, Miao J (2026) Microglia\u2013astrocyte crosstalk as a key organizing principle of Alzheimer\u2019s disease: from homeostatic cooperation to maladaptive signaling loops. Front Aging Neurosci 18:1908574","journal-title":"Front Aging Neurosci"},{"key":"2433_CR57","doi-asserted-by":"publisher","first-page":"e90633","DOI":"10.7554\/eLife.90633","volume":"13","author":"A Granzotto","year":"2024","unstructured":"Granzotto A, Vissel B, Sensi SL (2024) Lost in translation: inconvenient truths on the utility of mouse models in Alzheimer\u2019s disease research. eLife 13:e90633. https:\/\/doi.org\/10.7554\/eLife.90633","journal-title":"eLife"},{"key":"2433_CR58","doi-asserted-by":"publisher","first-page":"1645298","DOI":"10.3389\/fmicb.2025.1645298","volume":"16","author":"Y Guo","year":"2025","unstructured":"Guo Y, Zhang N, Pei D (2025) Gut microbiota heterogeneity in non-alcoholic fatty liver disease: a narrative review of drivers, mechanisms, and clinical relevance. Front Microbiol 16:1645298. https:\/\/doi.org\/10.3389\/fmicb.2025.1645298","journal-title":"Front Microbiol"},{"issue":"10","key":"2433_CR59","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL, Cho M, Lannfelt L, Cummings JL, Vergallo A (2021) The amyloid-beta pathway in Alzheimer\u2019s disease. Mol Psychiatry 26(10):5481\u20135503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0","journal-title":"Mol Psychiatry"},{"key":"2433_CR60","doi-asserted-by":"publisher","first-page":"1575453","DOI":"10.3389\/fnins.2025.1575453","volume":"19","author":"J Han","year":"2025","unstructured":"Han J, Zhang Z, Zhang P, Yu Q, Cheng Q, Lu Z, Zong S (2025) The roles of microglia and astrocytes in neuroinflammation of Alzheimer\u2019s disease. Front NeuroSci 19:1575453","journal-title":"Front NeuroSci"},{"issue":"1","key":"2433_CR61","doi-asserted-by":"publisher","first-page":"41802","DOI":"10.1038\/srep41802","volume":"7","author":"T Harach","year":"2017","unstructured":"Harach T, Marungruang N, Duthilleul N, Cheatham V, Mc Coy K, Frisoni G, Neher J, F\u00e5k F, Jucker M, Lasser T (2017) Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci Rep 7(1):41802","journal-title":"Sci Rep"},{"issue":"3","key":"2433_CR62","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/01.rvi.0000058421.01661.c5","volume":"14","author":"JR Harris","year":"2003","unstructured":"Harris JR, Fan CM, Geller SC, Brewster DC, Greenfield AJ, Santilli JG, Waltman AC (2003) Renal perfusion defects after endovascular repair of abdominal aortic aneurysms. J Vasc Interv Radiol 14(3):329\u2013333. https:\/\/doi.org\/10.1097\/01.rvi.0000058421.01661.c5","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"2433_CR63","doi-asserted-by":"publisher","first-page":"300060520925930","DOI":"10.1177\/0300060520925930","volume":"48","author":"S Hazan","year":"2020","unstructured":"Hazan S (2020) Rapid improvement in Alzheimer\u2019s disease symptoms following fecal microbiota transplantation: a case report. J Int Med Res 48(6):300060520925930. https:\/\/doi.org\/10.1177\/0300060520925930","journal-title":"J Int Med Res"},{"key":"2433_CR64","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.2147\/JIR.S422114","volume":"16","author":"C He","year":"2023","unstructured":"He C, Li Z, Yang M, Yu W, Luo R, Zhou J, He J, Chen Q, Song Z, Cheng S (2023) Non-coding RNA in microglia activation and neuroinflammation in Alzheimer\u2019s disease. J Inflamm Res 16:4165\u20134211. https:\/\/doi.org\/10.2147\/JIR.S422114","journal-title":"J Inflamm Res"},{"issue":"1","key":"2433_CR65","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s12035-025-05602-0","volume":"63","author":"ZM Hein","year":"2026","unstructured":"Hein ZM, Karikalan B, Gopalakrishna PK, Dhevi K, Alkatiri A, Hussan F, Mohd Moklas MA, Jagadeesan S, Che Ramli MD, Che Mohd Nassir CM, Vishnumukkala T (2026) Toward a unified framework in molecular neurobiology of Alzheimer\u2019s disease: revisiting the pathophysiological hypotheses. Mol Neurobiol 63(1):282","journal-title":"Mol Neurobiol"},{"issue":"20","key":"2433_CR66","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.3390\/nu15204365","volume":"15","author":"FS Heravi","year":"2023","unstructured":"Heravi FS, Naseri K, Hu H (2023) Gut microbiota composition in patients with neurodegenerative disorders (Parkinson\u2019s and Alzheimer\u2019s) and healthy controls: a systematic review. Nutrients 15(20):4365. https:\/\/doi.org\/10.3390\/nu15204365","journal-title":"Nutrients"},{"issue":"2","key":"2433_CR67","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jamaneurol.2019.3762","volume":"77","author":"R Howard","year":"2020","unstructured":"Howard R, Zubko O, Bradley R, Harper E, Pank L, O\u2019brien J, Fox C, Tabet N, Livingston G, Bentham P (2020) Minocycline at 2 different dosages vs placebo for patients with mild Alzheimer disease: a randomized clinical trial. JAMA Neurol 77(2):164\u2013174","journal-title":"JAMA Neurol"},{"issue":"1","key":"2433_CR68","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/nu16010016","volume":"16","author":"YC Hsu","year":"2023","unstructured":"Hsu YC, Huang YY, Tsai SY, Kuo YW, Lin JH, Ho HH, Chen JF, Hsia KC, Sun Y (2023) Efficacy of probiotic supplements on brain-derived neurotrophic factor, inflammatory biomarkers, oxidative stress and cognitive function in patients with Alzheimer\u2019s dementia: a 12-week randomized, double-blind active-controlled study. Nutrients 16(1):16. https:\/\/doi.org\/10.3390\/nu16010016","journal-title":"Nutrients"},{"key":"2433_CR69","unstructured":"Hu X (2024) Hippocampus-to-ventricle-ratio (HVR) as a novel biomarker for early diagnosis of Alzheimer disease (AD) Universit\u00e4t Konstanz]"},{"issue":"3","key":"2433_CR71","doi-asserted-by":"publisher","first-page":"858","DOI":"10.14336\/AD.2022.0916","volume":"14","author":"Y Huang","year":"2023","unstructured":"Huang Y, Zhao M, Chen X, Zhang R, Le A, Hong M, Zhang Y, Jia L, Zang W, Jiang C, Wang J, Fan X, Wang J (2023) Tryptophan metabolism in central nervous system diseases: pathophysiology and potential therapeutic strategies. Aging Dis 14(3):858\u2013878. https:\/\/doi.org\/10.14336\/AD.2022.0916","journal-title":"Aging Dis"},{"key":"2433_CR70","doi-asserted-by":"publisher","first-page":"1656732","DOI":"10.3389\/fcell.2025.1656732","volume":"13","author":"M Huang","year":"2025","unstructured":"Huang M, Yao G, He B, Zhou X, Liu G, Dong W (2025) Microglia and programmed cell death in spinal cord injury: beyond apoptosis. Front Cell Dev Biol 13:1656732. https:\/\/doi.org\/10.3389\/fcell.2025.1656732","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2433_CR72","doi-asserted-by":"publisher","first-page":"477","DOI":"10.18632\/aging.203826","volume":"14","author":"CC Hung","year":"2022","unstructured":"Hung CC, Chang CC, Huang CW, Nouchi R, Cheng CH (2022) Gut microbiota in patients with Alzheimer\u2019s disease spectrum: a systematic review and meta-analysis. Aging 14(1):477\u2013496. https:\/\/doi.org\/10.18632\/aging.203826","journal-title":"Aging"},{"issue":"6","key":"2433_CR73","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/0115426503018006461","volume":"18","author":"A Jabbar","year":"2003","unstructured":"Jabbar A, Chang WK, Dryden GW, McClave SA (2003) Gut immunology and the differential response to feeding and starvation. Nutr Clin Pract 18(6):461\u2013482. https:\/\/doi.org\/10.1177\/0115426503018006461","journal-title":"Nutr Clin Pract"},{"issue":"1","key":"2433_CR74","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s44400-026-00091-x","volume":"2","author":"J Jaeger","year":"2026","unstructured":"Jaeger J, Staats KA, Barnum S, Pope P, Kingery L, Buitendyk M, Cohen S, Tansey MG, Tesi RJ, Barnum CJ (2026) XPro1595 in early Alzheimer\u2019s disease with inflammation: results from the phase 2 MINDFuL trial. npj Dement 2(1):37","journal-title":"npj Dement"},{"issue":"1","key":"2433_CR75","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/medicina61010108","volume":"61","author":"YJ Jang","year":"2025","unstructured":"Jang YJ, Kim MJ, Lee SJ, Lim SW, Kim DK (2025) Oxidative stress and risk of dementia in older patients with depression: a longitudinal Cohort study using plasma biomarkers. Med (Kaunas) 61(1):108. https:\/\/doi.org\/10.3390\/medicina61010108","journal-title":"Med (Kaunas)"},{"issue":"6","key":"2433_CR76","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/febs.17124","volume":"292","author":"M Jans","year":"2025","unstructured":"Jans M, Vereecke L (2025) A guide to germ-free and gnotobiotic mouse technology to study health and disease. FEBS J 292(6):1228\u20131251. https:\/\/doi.org\/10.1111\/febs.17124","journal-title":"FEBS J"},{"issue":"5","key":"2433_CR77","doi-asserted-by":"publisher","first-page":"e0285346","DOI":"10.1371\/journal.pone.0285346","volume":"18","author":"S Jemimah","year":"2023","unstructured":"Jemimah S, Chabib CMM, Hadjileontiadis L, AlShehhi A (2023) Gut microbiome dysbiosis in Alzheimer\u2019s disease and mild cognitive impairment: a systematic review and meta-analysis. PLoS ONE 18(5):e0285346. https:\/\/doi.org\/10.1371\/journal.pone.0285346","journal-title":"PLoS ONE"},{"issue":"2","key":"2433_CR78","doi-asserted-by":"publisher","first-page":"240","DOI":"10.17305\/bb.2025.12921","volume":"26","author":"X Ji","year":"2025","unstructured":"Ji X, Wang J, Lan T, Zhao D, Xu P (2025) Gut microbial metabolites and the brain-gut axis in Alzheimer\u2019s disease: a review. Biomol Biomed 26(2):240\u2013250. https:\/\/doi.org\/10.17305\/bb.2025.12921","journal-title":"Biomol Biomed"},{"issue":"2","key":"2433_CR79","first-page":"1655","volume":"5","author":"X Jiang","year":"2025","unstructured":"Jiang X, Chi Y, Zhang D, Gao H, Chai R, Liu Y, Zhong L (2025) Research advances regarding the role of the AHR signaling pathway in Alzheimer\u2019s disease. Curr Sci 5(2):1655\u20131670","journal-title":"Curr Sci"},{"issue":"4","key":"2433_CR80","doi-asserted-by":"publisher","first-page":"e70057","DOI":"10.1002\/dad2.70057","volume":"16","author":"AM Jimenez-Garcia","year":"2024","unstructured":"Jimenez-Garcia AM, Villarino M, Arias N (2024) A systematic review and meta-analysis of basal microbiota and cognitive function in Alzheimer\u2019s disease: a potential target for treatment or a contributor to disease progression? Alzheimers Dement (Amst) 16(4):e70057. https:\/\/doi.org\/10.1002\/dad2.70057","journal-title":"Alzheimers Dement (Amst)"},{"issue":"6408","key":"2433_CR81","doi-asserted-by":"publisher","first-page":"eaat5236","DOI":"10.1126\/science.aat5236","volume":"361","author":"MM Kaelberer","year":"2018","unstructured":"Kaelberer MM, Buchanan KL, Klein ME, Barth BB, Montoya MM, Shen X, Bohorquez DV (2018) A gut-brain neural circuit for nutrient sensory transduction. Science 361(6408):eaat5236. https:\/\/doi.org\/10.1126\/science.aat5236","journal-title":"Science"},{"key":"2433_CR82","doi-asserted-by":"publisher","first-page":"1118529","DOI":"10.3389\/fmicb.2023.1118529","volume":"14","author":"K Kasarello","year":"2023","unstructured":"Kasarello K, Cudnoch-Jedrzejewska A, Czarzasta K (2023) Communication of gut microbiota and brain via immune and neuroendocrine signaling. Front Microbiol 14:1118529. https:\/\/doi.org\/10.3389\/fmicb.2023.1118529","journal-title":"Front Microbiol"},{"issue":"6","key":"2433_CR83","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41423-026-01412-z","volume":"23","author":"CH Kim","year":"2026","unstructured":"Kim CH (2026) Short-, medium-, versus long-chain fatty acids: mechanisms of immunomodulation and disease pathogenesis. Cell Mol Immunol 23(6):594\u2013606. https:\/\/doi.org\/10.1038\/s41423-026-01412-z","journal-title":"Cell Mol Immunol"},{"key":"2433_CR84","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.bbi.2024.08.051","volume":"122","author":"H Kim","year":"2024","unstructured":"Kim H, Lee E, Park M, Min K, Diep YN, Kim J, Ahn H, Lee E, Kim S, Kim Y (2024) Microbiome-derived indole-3-lactic acid reduces amyloidopathy through aryl-hydrocarbon receptor activation. Brain Behav Immun 122:568\u2013582","journal-title":"Brain Behav Immun"},{"issue":"6","key":"2433_CR86","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jalz.2012.09.012","volume":"9","author":"M Kivipelto","year":"2013","unstructured":"Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R, Backman L, Hanninen T, Jula A, Laatikainen T, Lindstrom J, Mangialasche F, Nissinen A, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Soininen H (2013) The finnish geriatric intervention study to prevent cognitive impairment and disability (FINGER): study design and progress. Alzheimers Dement 9(6):657\u2013665. https:\/\/doi.org\/10.1016\/j.jalz.2012.09.012","journal-title":"Alzheimers Dement"},{"issue":"7","key":"2433_CR85","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/alz.12123","volume":"16","author":"M Kivipelto","year":"2020","unstructured":"Kivipelto M, Mangialasche F, Snyder HM, Allegri R, Andrieu S, Arai H, Baker L, Belleville S, Brodaty H, Brucki SM, Calandri I, Caramelli P, Chen C, Chertkow H, Chew E, Choi SH, Chowdhary N, Crivelli L, Torre R, Carrillo MC (2020) World-wide FINGERS network: a global approach to risk reduction and prevention of dementia. Alzheimers Dement 16(7):1078\u20131094. https:\/\/doi.org\/10.1002\/alz.12123","journal-title":"Alzheimers Dement"},{"issue":"3\u20134","key":"2433_CR87","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1089\/ars.2005.7.385","volume":"7","author":"M Kobayashi","year":"2005","unstructured":"Kobayashi M, Yamamoto M (2005) Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal 7(3\u20134):385\u2013394. https:\/\/doi.org\/10.1089\/ars.2005.7.385","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"2433_CR89","doi-asserted-by":"publisher","first-page":"13510","DOI":"10.1038\/s41598-017-13368-2","volume":"7","author":"Y Kobayashi","year":"2017","unstructured":"Kobayashi Y, Sugahara H, Shimada K, Mitsuyama E, Kuhara T, Yasuoka A, Kondo T, Abe K, Xiao JZ (2017) Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer\u2019s disease. Sci Rep 7(1):13510. https:\/\/doi.org\/10.1038\/s41598-017-13368-2","journal-title":"Sci Rep"},{"issue":"1","key":"2433_CR88","doi-asserted-by":"publisher","first-page":"70","DOI":"10.14283\/jpad.2018.32","volume":"6","author":"Y Kobayashi","year":"2019","unstructured":"Kobayashi Y, Kinoshita T, Matsumoto A, Yoshino K, Saito I, Xiao JZ (2019) Bifidobacterium breve A1 supplementation improved cognitive decline in older adults with mild cognitive impairment: an open-label, single-arm study. J Prev Alzheimers Dis 6(1):70\u201375. https:\/\/doi.org\/10.14283\/jpad.2018.32","journal-title":"J Prev Alzheimers Dis"},{"issue":"40","key":"2433_CR90","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.2174\/1381612822666160907093807","volume":"22","author":"CA Kohler","year":"2016","unstructured":"Kohler CA, Maes M, Slyepchenko A, Berk M, Solmi M, Lanctot KL, Carvalho AF (2016) The gut-brain axis, including the microbiome, leaky gut and bacterial translocation: mechanisms and pathophysiological role in Alzheimer\u2019s disease. Curr Pharm Des 22(40):6152\u20136166. https:\/\/doi.org\/10.2174\/1381612822666160907093807","journal-title":"Curr Pharm Des"},{"issue":"1","key":"2433_CR91","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00702-021-02440-x","volume":"129","author":"K Kowalski","year":"2022","unstructured":"Kowalski K, Mulak A (2022) Small intestinal bacterial overgrowth in Alzheimer\u2019s disease. J Neural Transm (Vienna) 129(1):75\u201383. https:\/\/doi.org\/10.1007\/s00702-021-02440-x","journal-title":"J Neural Transm (Vienna)"},{"key":"2433_CR92","doi-asserted-by":"publisher","first-page":"9741811","DOI":"10.1155\/2024\/9741811","volume":"2024","author":"S Kozhakhmetov","year":"2024","unstructured":"Kozhakhmetov S, Kaiyrlykyzy A, Jarmukhanov Z, Vinogradova E, Zholdasbekova G, Alzhanova D, Kunz J, Kushugulova A, Askarova S (2024) Inflammatory manifestations associated with gut dysbiosis in Alzheimer\u2019s disease. Int J Alzheimers Dis 2024:9741811. https:\/\/doi.org\/10.1155\/2024\/9741811","journal-title":"Int J Alzheimers Dis"},{"issue":"18","key":"2433_CR93","doi-asserted-by":"publisher","first-page":"9178","DOI":"10.3390\/ijms26189178","volume":"26","author":"A Krsek","year":"2025","unstructured":"Krsek A, Schleicher LMS, Jagodic A, Baticic L (2025) Nanomedicine-driven modulation of the gut-brain axis: innovative approaches to managing chronic inflammation in alzheimer\u2019s and Parkinson\u2019s disease. Int J Mol Sci 26(18):9178. https:\/\/doi.org\/10.3390\/ijms26189178","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2433_CR94","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s44400-025-00048-6","volume":"1","author":"S Kumari","year":"2025","unstructured":"Kumari S, Desai V, Sivakumar S, Sikri K, Kumar M (2025) Association between gut microbial dysbiosis and Alzheimer\u2019s disease: an umbrella review. npj Dement 1(1):41. https:\/\/doi.org\/10.1038\/s44400-025-00048-6","journal-title":"npj Dement"},{"key":"2433_CR95","doi-asserted-by":"publisher","first-page":"1266955","DOI":"10.3389\/fnagi.2023.1266955","volume":"15","author":"EH Lee","year":"2023","unstructured":"Lee EH, Kim GH, Park HK, Kang HJ, Park YK, Lee HA, Hong CH, Moon SY, Kang W, Oh HS, Yoon HJ, Choi SH, Jeong JH (2023) Effects of the multidomain intervention with nutritional supplements on cognition and gut microbiome in early symptomatic Alzheimer\u2019s disease: a randomized controlled trial. Front Aging Neurosci 15:1266955. https:\/\/doi.org\/10.3389\/fnagi.2023.1266955","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"2433_CR96","doi-asserted-by":"publisher","first-page":"205","DOI":"10.59249\/JNKB9714","volume":"97","author":"JY Lee","year":"2024","unstructured":"Lee JY, Wong CY, Koh RY, Lim CL, Kok YY, Chye SM (2024) Natural bioactive compounds from macroalgae and microalgae for the treatment of Alzheimer\u2019s disease: a review. Yale J Biol Med 97(2):205\u2013224. https:\/\/doi.org\/10.59249\/JNKB9714","journal-title":"Yale J Biol Med"},{"issue":"1","key":"2433_CR97","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s40364-025-00851-6","volume":"13","author":"J Li","year":"2025","unstructured":"Li J, Yuan Z, Li J, Liu Z, Wang Y, Cui M, Suo C, Jin L, Ding D, Chen X, Jiang Y (2025a) Immune, blood-brain barrier, and metabolic biomarkers mediate gut-brain axis crosstalk in alzheimer\u2019s disease. Biomark Res 13(1):137. https:\/\/doi.org\/10.1186\/s40364-025-00851-6","journal-title":"Biomark Res"},{"issue":"48","key":"2433_CR98","doi-asserted-by":"publisher","first-page":"eadw8410","DOI":"10.1126\/sciadv.adw8410","volume":"11","author":"L Li","year":"2025","unstructured":"Li L, Jia M, Yang C, Zhao Y, Hu J, Zhao Y, Hu X, Ning F, Ding C, Li Q, Gong J, Jia X, Xu K, Wang Y, Zhou S, Deng L, Shi L, Chen X, Liu X, Liu Z (2025b) Gut microbial-derived indole-3-propionate improves cognitive function in Alzheimer\u2019s disease. Sci Adv 11(48):eadw8410. https:\/\/doi.org\/10.1126\/sciadv.adw8410","journal-title":"Sci Adv"},{"issue":"8","key":"2433_CR99","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1002\/alz.14057","volume":"20","author":"Y Liang","year":"2024","unstructured":"Liang Y, Liu C, Cheng M, Geng L, Li J, Du W, Song M, Chen N, Yeleen TAN, Song L (2024) The link between gut microbiome and Alzheimer\u2019s disease: from the perspective of new revised criteria for diagnosis and staging of Alzheimer\u2019s disease. Alzheimer\u2019s Dement 20(8):5771\u20135788","journal-title":"Alzheimer\u2019s Dement"},{"issue":"4","key":"2433_CR100","doi-asserted-by":"publisher","first-page":"212","DOI":"10.12793\/tcp.2025.33.e19","volume":"33","author":"S Lim","year":"2025","unstructured":"Lim S, Lee HW, Yoon S, Han JW, Chung JY, Yoon S (2025) Sex differences in efficacy\/safety of anti-amyloid-beta monoclonal antibodies for the treatment of Alzheimer\u2019s disease. Transl Clin Pharmacol 33(4):212\u2013223. https:\/\/doi.org\/10.12793\/tcp.2025.33.e19","journal-title":"Transl Clin Pharmacol"},{"issue":"7","key":"2433_CR102","doi-asserted-by":"publisher","first-page":"e70037","DOI":"10.1111\/1750-3841.70037","volume":"90","author":"W Liu","year":"2025","unstructured":"Liu W, Guo J, Dong Y, Li J, Wang Y (2025) Efficacy of probiotic supplementation in influencing cognitive function in Alzheimer\u2019s disease: a systematic review and meta-analysis. J Food Sci 90(7):e70037. https:\/\/doi.org\/10.1111\/1750-3841.70037","journal-title":"J Food Sci"},{"issue":"7","key":"2433_CR101","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41568-026-00922-2","volume":"26","author":"F Liu","year":"2026","unstructured":"Liu F, Beck S, Yang L, Luo H, Zhang K (2026) Advancing AI for multi-omics and clinical data integration in basic and translational cancer research. Nat Rev Cancer 26(7):497\u2013512. https:\/\/doi.org\/10.1038\/s41568-026-00922-2","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"2433_CR103","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.3390\/ani16081174","volume":"16","author":"F Loewenstein","year":"2026","unstructured":"Loewenstein F, Mascher S, Frey T, Lechner M (2026) Feeding of undocked pigs: effects of feed components and feed composition. Animal 16(8):1174. https:\/\/doi.org\/10.3390\/ani16081174","journal-title":"Anim (Basel)"},{"issue":"9","key":"2433_CR104","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.7150\/ijms.135274","volume":"23","author":"P Lu","year":"2026","unstructured":"Lu P, Liu M, Zhang L, Fan JJ, Sun Y (2026) Synergistic regulation of Alzheimer\u2019s disease and intestinal microbiota metabolism mediated by the gut-brain axis: a comprehensive analysis from a multidisciplinary perspective. Int J Med Sci 23(9):2939\u20132962. https:\/\/doi.org\/10.7150\/ijms.135274","journal-title":"Int J Med Sci"},{"issue":"5","key":"2433_CR105","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ejmg.2005.12.004","volume":"49","author":"PC Mainardi","year":"2006","unstructured":"Mainardi PC, Pastore G, Castronovo C, Godi M, Guala A, Tamiazzo S, Provera S, Pierluigi M, Bricarelli FD (2006) The natural history of Cri du chat syndrome. A report from the Italian register. Eur J Med Genet 49(5):363\u2013383. https:\/\/doi.org\/10.1016\/j.ejmg.2005.12.004","journal-title":"Eur J Med Genet"},{"issue":"1","key":"2433_CR106","doi-asserted-by":"publisher","first-page":"8142006","DOI":"10.1155\/agm3\/8142006","volume":"2026","author":"M Mart\u00ednez-Porchas","year":"2026","unstructured":"Mart\u00ednez-Porchas M, Medina-F\u00e9lix D, Olivas Bernal CA, Guirado-Flores JO, Vargas-Albores F, Porchas-Quijada M, Garibay-Valdez E (2026) Microbiota\u2013gut\u2013brain axis: an integrative overview of communication pathways. Adv Gut Microbiome Res 2026(1):8142006","journal-title":"Adv Gut Microbiome Res"},{"key":"2433_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-0-387-09550-9_1","volume":"635","author":"KL Mason","year":"2008","unstructured":"Mason KL, Huffnagle GB, Noverr MC, Kao JY (2008) Overview of gut immunology. Adv Exp Med Biol 635:1\u201314. https:\/\/doi.org\/10.1007\/978-0-387-09550-9_1","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"2433_CR108","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3390\/molecules21091243","volume":"21","author":"G Mazzanti","year":"2016","unstructured":"Mazzanti G, Di Giacomo S (2016) Curcumin and resveratrol in the management of cognitive disorders: what is the clinical evidence? Molecules 21(9):1243","journal-title":"Molecules"},{"issue":"1","key":"2433_CR109","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s44400-026-00067-x","volume":"2","author":"E McDade","year":"2026","unstructured":"McDade E, Porsteinsson A, Clifford D, Llibre-Guerra J, Wang G, Li Y, Belyew S, Mills S, Santacruz A, Supnet-Bell C (2026) Primary prevention of Alzheimer disease in dominantly inherited Alzheimer network: a platform trial design. npj Dement 2(1):40","journal-title":"npj Dement"},{"key":"2433_CR110","unstructured":"McGlasson SL (2015) Regulation of the innate immune system. University of Edinburgh]"},{"issue":"1","key":"2433_CR111","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bcp.2013.08.006","volume":"87","author":"P McGonigle","year":"2014","unstructured":"McGonigle P, Ruggeri B (2014) Animal models of human disease: challenges in enabling translation. Biochem Pharmacol 87(1):162\u2013171. https:\/\/doi.org\/10.1016\/j.bcp.2013.08.006","journal-title":"Biochem Pharmacol"},{"key":"2433_CR112","doi-asserted-by":"publisher","unstructured":"Merkel J, Perneczky R, Jessen F, Frolich L, Jansen O, Peters S, Berg D, Schulz JB, Bartsch T (2026) Amyloid-related imaging abnormalities (ARIA) in Alzheimer\u2019s disease: from pathophysiology to individualized risk assessment. Alzheimers Res Ther 18(1). https:\/\/doi.org\/10.1186\/s13195-026-02022-7","DOI":"10.1186\/s13195-026-02022-7"},{"issue":"3","key":"2433_CR113","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1007\/s00415-021-10567-w","volume":"269","author":"V Metta","year":"2022","unstructured":"Metta V, Leta V, Mrudula KR, Prashanth LK, Goyal V, Borgohain R, Chung-Faye G, Chaudhuri KR (2022) Gastrointestinal dysfunction in Parkinson\u2019s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation. J Neurol 269(3):1154\u20131163. https:\/\/doi.org\/10.1007\/s00415-021-10567-w","journal-title":"J Neurol"},{"issue":"3","key":"2433_CR114","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.3390\/ijms15034671","volume":"15","author":"A Mietelska-Porowska","year":"2014","unstructured":"Mietelska-Porowska A, Wasik U, Goras M, Filipek A, Niewiadomska G (2014) Tau protein modifications and interactions: their role in function and dysfunction. Int J Mol Sci 15(3):4671\u20134713","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2433_CR115","doi-asserted-by":"publisher","first-page":"30028","DOI":"10.1038\/srep30028","volume":"6","author":"MR Minter","year":"2016","unstructured":"Minter MR, Zhang C, Leone V, Ringus DL, Zhang X, Oyler-Castrillo P, Musch MW, Liao F, Ward JF, Holtzman DM, Chang EB, Tanzi RE, Sisodia SS (2016) Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer\u2019s disease. Sci Rep 6(1):30028. https:\/\/doi.org\/10.1038\/srep30028","journal-title":"Sci Rep"},{"issue":"2","key":"2433_CR116","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s11357-025-02062-1","volume":"48","author":"PA Mir","year":"2026","unstructured":"Mir PA, Kumar N, Bhutia GT, Chaudhary P, Kaur G, Gupta SK (2026) The aging gut-glia-immune axis in alzheimer\u2019s disease: microbiome-derived mediators of neuroinflammation and therapeutic innovation. Geroscience 48(2):2201\u20132241. https:\/\/doi.org\/10.1007\/s11357-025-02062-1","journal-title":"Geroscience"},{"key":"2433_CR117","doi-asserted-by":"publisher","first-page":"e5166","DOI":"10.7717\/peerj.5166","volume":"6","author":"J Miyoshi","year":"2018","unstructured":"Miyoshi J, Leone V, Nobutani K, Musch MW, Martinez-Guryn K, Wang Y, Miyoshi S, Bobe AM, Eren AM, Chang EB (2018) Minimizing confounders and increasing data quality in murine models for studies of the gut microbiome. PeerJ 6:e5166. https:\/\/doi.org\/10.7717\/peerj.5166","journal-title":"PeerJ"},{"key":"2433_CR118","doi-asserted-by":"publisher","first-page":"e102889","DOI":"10.1002\/alz70857_102889","volume":"21","author":"A Moeed","year":"2025","unstructured":"Moeed A, Waseem H, Siddiqui AH, Maria F, Yaqoob S, Jogezai ZH, Moosa M, Saif A, Bilal M, Batool F (2025) Effects of probiotics on oxidative, cognitive and metabolic outcomes in Alzheimer\u2019s dementia: a systematic review and meta-analysis of randomized controlled trials. Alzheimer\u2019s Dement 21:e102889","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"2433_CR119","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s12035-026-06004-6","volume":"63","author":"A Mohammadi","year":"2026","unstructured":"Mohammadi A, Aghajan A, Alipour M, Ghorbani A, Limoodehi SM, Ch MH (2026) LPS-induced neuroinflammation in neurodegenerative diseases: a double-edged sword? Mol Neurobiol 63(1):711. https:\/\/doi.org\/10.1007\/s12035-026-06004-6","journal-title":"Mol Neurobiol"},{"issue":"3","key":"2433_CR120","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/biof.1930","volume":"49","author":"G Montalto","year":"2023","unstructured":"Montalto G, Ricciarelli R (2023) Tau, tau kinases, and tauopathies: an updated overview. BioFactors 49(3):502\u2013511. https:\/\/doi.org\/10.1002\/biof.1930","journal-title":"BioFactors"},{"issue":"1\u20132","key":"2433_CR121","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1089\/ars.2005.7.269","volume":"7","author":"TJ Montine","year":"2005","unstructured":"Montine TJ, Montine KS, McMahan W, Markesbery WR, Quinn JF, Morrow JD (2005) F2-isoprostanes in Alzheimer and other neurodegenerative diseases. Antioxid Redox Signal 7(1\u20132):269\u2013275. https:\/\/doi.org\/10.1089\/ars.2005.7.269","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"2433_CR122","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/life16010175","volume":"16","author":"DM Morariu-Briciu","year":"2026","unstructured":"Morariu-Briciu DM, Jijie AR, Bolintineanu SL, Pah AM, Chiriac SD, Cheveresan A, Dumitrascu V, Barbulescu P, C., Jipa R (2026) Medicinal plants and phytochemicals in cardioprotection-mechanistic pathways and translational roadmap. Life (Basel) 16(1):175. https:\/\/doi.org\/10.3390\/life16010175","journal-title":"Life (Basel)"},{"key":"2433_CR123","doi-asserted-by":"publisher","first-page":"796288","DOI":"10.3389\/fimmu.2022.796288","volume":"13","author":"Y Mou","year":"2022","unstructured":"Mou Y, Du Y, Zhou L, Yue J, Hu X, Liu Y, Chen S, Lin X, Zhang G, Xiao H (2022) Gut microbiota interact with the brain through systemic chronic inflammation: implications on neuroinflammation, neurodegeneration, and aging. Front Immunol 13:796288","journal-title":"Front Immunol"},{"key":"2433_CR124","doi-asserted-by":"publisher","first-page":"607382","DOI":"10.2147\/IJN.S607382","volume":"21","author":"N Muhammad","year":"2026","unstructured":"Muhammad N (2026) Nanobiotic-enhanced probiotics for targeted gut delivery: mechanisms, therapeutic applications, and translational challenges. Int J Nanomed 21:607382. https:\/\/doi.org\/10.2147\/IJN.S607382","journal-title":"Int J Nanomed"},{"issue":"3","key":"2433_CR125","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/arclin\/acac008","volume":"37","author":"ER Murray","year":"2022","unstructured":"Murray ER, Kemp M, Nguyen TT (2022) The microbiota-gut-brain axis in Alzheimer\u2019s disease: a review of taxonomic alterations and potential avenues for interventions. Arch Clin Neuropsychol 37(3):595\u2013607. https:\/\/doi.org\/10.1093\/arclin\/acac008","journal-title":"Arch Clin Neuropsychol"},{"issue":"2","key":"2433_CR126","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, Abdoli A, Abualhasan A, Abu-Gharbieh E, Akram TT (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health 7(2):e105\u2013e125","journal-title":"Lancet Public Health"},{"key":"2433_CR127","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neuroscience.2015.01.040","volume":"290","author":"MK Nohr","year":"2015","unstructured":"Nohr MK, Egerod KL, Christiansen SH, Gille A, Offermanns S, Schwartz TW, Moller M (2015) Expression of the short chain fatty acid receptor GPR41\/FFAR3 in autonomic and somatic sensory ganglia. Neuroscience 290:126\u2013137. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.01.040","journal-title":"Neuroscience"},{"issue":"19","key":"2433_CR128","doi-asserted-by":"publisher","first-page":"14794","DOI":"10.3390\/ijms241914794","volume":"24","author":"KS Orobets","year":"2023","unstructured":"Orobets KS, Karamyshev AL (2023) Amyloid precursor protein and Alzheimer\u2019s disease. Int J Mol Sci 24(19):14794. https:\/\/doi.org\/10.3390\/ijms241914794","journal-title":"Int J Mol Sci"},{"key":"2433_CR129","doi-asserted-by":"publisher","first-page":"254248232614362","DOI":"10.1177\/25424823261436287","volume":"10","author":"TA Oso","year":"2026","unstructured":"Oso TA, Okesanya OJ, Adebayo UO, Obadeyi KB, Ayelaagbe OB, Talabi OA, Adewole PD, Anorue CO, Ahmed MM, Talabi OT, Ogaya JB, Lucero-Prisno DE (2026) Microbiome alterations in Alzheimer\u2019s disease: A systematic review of current evidence and global perspectives. J Alzheimers Dis Rep 10:25424823261436287. 3rdhttps:\/\/doi.org\/10.1177\/25424823261436287","journal-title":"J Alzheimers Dis Rep"},{"issue":"17","key":"2433_CR130","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.3390\/molecules30173628","volume":"30","author":"M Owe-Larsson","year":"2025","unstructured":"Owe-Larsson M, Drobek D, Iwaniak P, Kloc R, Urbanska EM, Chwil M (2025) Microbiota-derived tryptophan metabolite indole-3-propionic acid-emerging role in neuroprotection. Molecules 30(17):3628. https:\/\/doi.org\/10.3390\/molecules30173628","journal-title":"Molecules"},{"issue":"2","key":"2433_CR131","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/nu8020078","volume":"8","author":"T Ozdal","year":"2016","unstructured":"Ozdal T, Sela DA, Xiao J, Boyacioglu D, Chen F, Capanoglu E (2016) The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility. Nutrients 8(2):78","journal-title":"Nutrients"},{"issue":"1","key":"2433_CR132","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-025-00916-y","volume":"21","author":"MT Papavergi","year":"2025","unstructured":"Papavergi MT, Bathini P, Singh B, Lemere CA (2025) The complement cascade in Alzheimer\u2019s disease: modern implications of an ancient immune protagonist. Mol Neurodegener 21(1):5. https:\/\/doi.org\/10.1186\/s13024-025-00916-y","journal-title":"Mol Neurodegener"},{"key":"2433_CR133","doi-asserted-by":"publisher","first-page":"676621","DOI":"10.3389\/fimmu.2021.676621","volume":"12","author":"AP Passaro","year":"2021","unstructured":"Passaro AP, Lebos AL, Yao Y, Stice SL (2021) Immune response in neurological pathology: emerging role of central and peripheral immune crosstalk. Front Immunol 12:676621. https:\/\/doi.org\/10.3389\/fimmu.2021.676621","journal-title":"Front Immunol"},{"issue":"10","key":"2433_CR134","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.3390\/molecules22101692","volume":"22","author":"B Penke","year":"2017","unstructured":"Penke B, Bogar F, Fulop L (2017) beta-amyloid and the pathomechanisms of Alzheimer\u2019s disease: a comprehensive view. Molecules 22(10):1692. https:\/\/doi.org\/10.3390\/molecules22101692","journal-title":"Molecules"},{"issue":"5","key":"2433_CR135","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1111\/j.1476-5381.2012.01916.x","volume":"166","author":"AG Polson","year":"2012","unstructured":"Polson AG, Fuji RN (2012) The successes and limitations of preclinical studies in predicting the pharmacodynamics and safety of cell-surface-targeted biological agents in patients. Br J Pharmacol 166(5):1600\u20131602. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.01916.x","journal-title":"Br J Pharmacol"},{"issue":"4","key":"2433_CR136","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/pharmaceutics14040835","volume":"14","author":"P Poudel","year":"2022","unstructured":"Poudel P, Park S (2022) Recent advances in the treatment of Alzheimer\u2019s disease using nanoparticle-based drug delivery systems. Pharmaceutics 14(4):835. https:\/\/doi.org\/10.3390\/pharmaceutics14040835","journal-title":"Pharmaceutics"},{"issue":"11","key":"2433_CR137","doi-asserted-by":"publisher","first-page":"6684","DOI":"10.1007\/s12035-022-02990-5","volume":"59","author":"SS Praveenraj","year":"2022","unstructured":"Praveenraj SS, Sonali S, Anand N, Tousif HA, Vichitra C, Kalyan M, Kanna PV, Chandana KA, Shasthara P, Mahalakshmi AM, Yang J, Pandi-Perumal SR, Sakharkar MK, Chidambaram SB (2022) The role of a gut microbial-derived metabolite, trimethylamine N-Oxide (TMAO), in neurological disorders. Mol Neurobiol 59(11):6684\u20136700. https:\/\/doi.org\/10.1007\/s12035-022-02990-5","journal-title":"Mol Neurobiol"},{"key":"2433_CR138","doi-asserted-by":"crossref","unstructured":"Qiao L, Chen Y, Song X, Dou X, Xu C (2022) Selenium nanoparticles-enriched Lactobacillus casei ATCC 393 prevents cognitive dysfunction in mice through modulating microbiota-gut-brain axis. Int J Nanomed, 4807\u20134827","DOI":"10.2147\/IJN.S374024"},{"key":"2433_CR139","doi-asserted-by":"publisher","first-page":"1729708","DOI":"10.3389\/fmicb.2025.1729708","volume":"16","author":"R Qin","year":"2025","unstructured":"Qin R, Li C, Yuan X, Chen Y (2025) Microbiome-targeted Alzheimer\u2019s interventions via gut-brain axis. Front Microbiol 16:1729708. https:\/\/doi.org\/10.3389\/fmicb.2025.1729708","journal-title":"Front Microbiol"},{"key":"2433_CR140","doi-asserted-by":"crossref","unstructured":"Quansah M, David MA, Martins R, El-Omar E, Aliberti SM, Capunzo M, Jensen SO, Tayebi M (2025) The beneficial effects of Lactobacillus strains on gut microbiome in Alzheimer\u2019s disease: a systematic review. Healthcare","DOI":"10.3390\/healthcare13010074"},{"issue":"3","key":"2433_CR141","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4140\/TCP.n.2026.98","volume":"41","author":"MA Qudoos","year":"2026","unstructured":"Qudoos MA, Elliott DP (2026) Review of Donanemab and Lecanemab in mild dementia stage of Alzheimer\u2019s disease: progress and challenges. Sr Care Pharm 41(3):98\u2013108. https:\/\/doi.org\/10.4140\/TCP.n.2026.98","journal-title":"Sr Care Pharm"},{"issue":"5","key":"2433_CR142","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s43587-023-00410-4","volume":"3","author":"MS Rafii","year":"2023","unstructured":"Rafii MS, Aisen PS (2023) Detection and treatment of Alzheimer\u2019s disease in its preclinical stage. Nat Aging 3(5):520\u2013531. https:\/\/doi.org\/10.1038\/s43587-023-00410-4","journal-title":"Nat Aging"},{"issue":"8","key":"2433_CR143","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3390\/microorganisms13081956","volume":"13","author":"J Ren","year":"2025","unstructured":"Ren J, Wang Q, Hong H, Tang C (2025) Fecal microbiota transplantation in Alzheimer\u2019s disease: mechanistic insights through the microbiota\u2013gut\u2013brain axis and therapeutic prospects. Microorganisms 13(8):1956","journal-title":"Microorganisms"},{"key":"2433_CR144","unstructured":"Risen SJ (2025) The Neuroinflammatory nexus: glial dysfunction in the pathogenesis and therapeutic targeting of neurodegenerative and neurodevelopmental disorders. Colorado State University]"},{"key":"2433_CR145","doi-asserted-by":"publisher","first-page":"105046","DOI":"10.1016\/j.psyneuen.2020.105046","volume":"124","author":"S Rosin","year":"2021","unstructured":"Rosin S, Xia K, Azcarate-Peril MA, Carlson AL, Propper CB, Thompson AL, Grewen K, Knickmeyer RC (2021) A preliminary study of gut microbiome variation and HPA axis reactivity in healthy infants. Psychoneuroendocrinology 124:105046. https:\/\/doi.org\/10.1016\/j.psyneuen.2020.105046","journal-title":"Psychoneuroendocrinology"},{"issue":"18","key":"2433_CR146","doi-asserted-by":"publisher","first-page":"6478","DOI":"10.3390\/jcm14186478","volume":"14","author":"K Roszak","year":"2025","unstructured":"Roszak K, Roy K, Sobocinska J, Spisz P, Jedrzejewski T, Wrotek S (2025) Endotoxin\u2019s impact on organism: from immune activation to tolerance and beyond. J Clin Med 14(18):6478. https:\/\/doi.org\/10.3390\/jcm14186478","journal-title":"J Clin Med"},{"issue":"3","key":"2433_CR147","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/cells11030382","volume":"11","author":"F Sarubbo","year":"2022","unstructured":"Sarubbo F, Cavallucci V, Pani G (2022) The influence of gut microbiota on neurogenesis: evidence and hopes. Cells 11(3):382. https:\/\/doi.org\/10.3390\/cells11030382","journal-title":"Cells"},{"issue":"1","key":"2433_CR148","doi-asserted-by":"publisher","first-page":"28505","DOI":"10.1038\/s41598-025-13262-2","volume":"15","author":"V Sepulveda-Rivera","year":"2025","unstructured":"Sepulveda-Rivera V, Olivieri-Henry G, Morales-Gonzalez H, Ruiz-Adames J, Herrero-Rivera C, Rentas-Echeverria A, Cardona-Berdecia V, Soler-Llompart C, Sala-Morales AC, Perez-Montero G, Blanco-Ruiz E, Godoy-Vitorino F (2025) Gut microbiota distinguishes aging hispanics with Alzheimer\u2019s disease: associations with cognitive impairment and severity. Sci Rep 15(1):28505. https:\/\/doi.org\/10.1038\/s41598-025-13262-2","journal-title":"Sci Rep"},{"key":"2433_CR149","unstructured":"She X (2025) Targeting the synergistic interaction of pathologies in Alzheimer\u2019s disease: rationale and prospects for combination therapy. arXiv preprint arXiv:2512.10981"},{"issue":"1","key":"2433_CR150","doi-asserted-by":"publisher","first-page":"2471737","DOI":"10.1080\/13510002.2025.2471737","volume":"30","author":"S Shin","year":"2025","unstructured":"Shin S, Chen S, Xie K, Duhun SA, Ortiz-Cerda T (2025) Evaluating the anti-inflammatory and antioxidant efficacy of complementary and alternative medicines (CAM) used for management of inflammatory bowel disease: a comprehensive review. Redox Rep 30(1):2471737. https:\/\/doi.org\/10.1080\/13510002.2025.2471737","journal-title":"Redox Rep"},{"issue":"4","key":"2433_CR151","doi-asserted-by":"publisher","first-page":"708","DOI":"10.4103\/1673-5374.353484","volume":"18","author":"Z-Z Si","year":"2022","unstructured":"Si Z-Z, Zou C-J, Mei X, Li X-F, Luo H, Shen Y, Hu J, Li X-X, Wu L, Liu Y (2022) Targeting neuroinflammation in Alzheimer\u2019s disease: from mechanisms to clinical applications. Neural Regen Res 18(4):708","journal-title":"Neural regeneration Res"},{"key":"2433_CR152","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jclinepi.2016.05.015","volume":"79","author":"B Snilstveit","year":"2016","unstructured":"Snilstveit B, Vojtkova M, Bhavsar A, Stevenson J, Gaarder M (2016) Evidence & gap maps: a tool for promoting evidence informed policy and strategic research agendas. J Clin Epidemiol 79:120\u2013129. https:\/\/doi.org\/10.1016\/j.jclinepi.2016.05.015","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2433_CR153","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1038\/s41467-019-11674-z","volume":"10","author":"E Spangenberg","year":"2019","unstructured":"Spangenberg E, Severson PL, Hohsfield LA, Crapser J, Zhang J, Burton EA, Zhang Y, Spevak W, Lin J, Phan NY, Habets G, Rymar A, Tsang G, Walters J, Nespi M, Singh P, Broome S, Ibrahim P, Zhang C, Green KN (2019) Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer\u2019s disease model. Nat Commun 10(1):3758. https:\/\/doi.org\/10.1038\/s41467-019-11674-z","journal-title":"Nat Commun"},{"issue":"1","key":"2433_CR154","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/gbb.12109","volume":"13","author":"RM Stilling","year":"2014","unstructured":"Stilling RM, Dinan TG, Cryan JF (2014) Microbial genes, brain & behaviour\u2013epigenetic regulation of the gut\u2013brain axis. Genes Brain Behav 13(1):69\u201386","journal-title":"Genes Brain Behav"},{"issue":"20","key":"2433_CR155","doi-asserted-by":"publisher","first-page":"7551","DOI":"10.3390\/ijms21207551","volume":"21","author":"K Suganya","year":"2020","unstructured":"Suganya K, Koo B-S (2020) Gut\u2013brain axis: role of gut microbiota on neurological disorders and how probiotics\/prebiotics beneficially modulate microbial and immune pathways to improve brain functions. Int J Mol Sci 21(20):7551","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2433_CR156","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41398-019-0525-3","volume":"9","author":"J Sun","year":"2019","unstructured":"Sun J, Xu J, Ling Y, Wang F, Gong T, Yang C, Ye S, Ye K, Wei D, Song Z, Chen D, Liu J (2019) Fecal microbiota transplantation alleviated Alzheimer\u2019s disease-like pathogenesis in APP\/PS1 transgenic mice. Transl Psychiatry 9(1):189. https:\/\/doi.org\/10.1038\/s41398-019-0525-3","journal-title":"Transl Psychiatry"},{"issue":"3","key":"2433_CR157","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14(3):133\u2013150. https:\/\/doi.org\/10.1038\/nrneurol.2017.188","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"2433_CR158","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s40265-020-01268-1","volume":"80","author":"YY Syed","year":"2020","unstructured":"Syed YY (2020) Sodium oligomannate: first approval: YY Syed. Drugs 80(4):441\u2013444","journal-title":"Drugs"},{"issue":"10","key":"2433_CR159","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/neurolint17100155","volume":"17","author":"C Tana","year":"2025","unstructured":"Tana C, Moffa S, Tana M, Ucciferri C, Moffa L (2025) Gut microbiota, mild cognitive impairment and dementia: a systematic review. Neurol Int 17(10):155. https:\/\/doi.org\/10.3390\/neurolint17100155","journal-title":"Neurol Int"},{"key":"2433_CR160","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.2147\/IDR.S254403","volume":"13","author":"W Tang","year":"2020","unstructured":"Tang W, Zhu H, Feng Y, Guo R, Wan D (2020) The impact of gut microbiota disorders on the blood-brain barrier. Infect Drug Resist 13:3351\u20133363. https:\/\/doi.org\/10.2147\/IDR.S254403","journal-title":"Infect Drug Resist"},{"issue":"1","key":"2433_CR161","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/receptors4010002","volume":"4","author":"LC Teixeira","year":"2025","unstructured":"Teixeira LC, Luizon MR, Gomes KB (2025) Exploring the role of GLP-1 receptor agonists in Alzheimer\u2019s disease: a review of preclinical and clinical evidence. Receptors 4(1):2","journal-title":"Receptors"},{"issue":"7","key":"2433_CR162","doi-asserted-by":"publisher","first-page":"e1316","DOI":"10.1002\/iid3.1316","volume":"12","author":"K Tian","year":"2024","unstructured":"Tian K, Jing D, Lan J, Lv M, Wang T (2024) Commensal microbiome and gastrointestinal mucosal immunity: harmony and conflict with our closest neighbor. Immun Inflamm Dis 12(7):e1316","journal-title":"Immun Inflamm Dis"},{"key":"2433_CR163","doi-asserted-by":"crossref","unstructured":"Tirado LAR (2025) Effects of peripheral inflammation and neuroinflammation on clinical and neuroimaging outcomes across the Alzheimer\u2019s disease spectrum University of Pittsburgh]","DOI":"10.1002\/alz70862_110253"},{"key":"2433_CR164","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.2147\/IJN.S200490","volume":"14","author":"S Tiwari","year":"2019","unstructured":"Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M (2019) Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomed 14:5541\u20135554. https:\/\/doi.org\/10.2147\/IJN.S200490","journal-title":"Int J Nanomed"},{"issue":"7","key":"2433_CR165","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1021\/acschemneuro.7b00176","volume":"8","author":"JK Tse","year":"2017","unstructured":"Tse JK (2017) Gut microbiota, nitric oxide, and microglia as prerequisites for neurodegenerative disorders. ACS Chem Neurosci 8(7):1438\u20131447","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"2433_CR167","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3233\/JAD-210268","volume":"83","author":"M Van Zeller","year":"2021","unstructured":"Van Zeller M, Dias D, Sebastiao AM, Valente CA (2021) NLRP3 Inflammasome: a starring role in amyloid-beta- and tau-driven pathological events in Alzheimer\u2019s disease. J Alzheimers Dis 83(3):939\u2013961. https:\/\/doi.org\/10.3233\/JAD-210268","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"2433_CR168","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3390\/antiox10071069","volume":"10","author":"F Villavicencio Tejo","year":"2021","unstructured":"Villavicencio Tejo F, Quintanilla RA (2021) Contribution of the Nrf2 pathway on oxidative damage and mitochondrial failure in Parkinson and Alzheimer\u2019s disease. Antioxide 10(7):1069. https:\/\/doi.org\/10.3390\/antiox10071069","journal-title":"Antioxid (Basel)"},{"issue":"1","key":"2433_CR169","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s40478-019-0754-y","volume":"7","author":"T Vogels","year":"2019","unstructured":"Vogels T, Murgoci A-N, Hrom\u00e1dka T (2019) Intersection of pathological tau and microglia at the synapse. Acta Neuropathol Commun 7(1):109","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2433_CR170","doi-asserted-by":"publisher","first-page":"13537","DOI":"10.1038\/s41598-017-13601-y","volume":"7","author":"NM Vogt","year":"2017","unstructured":"Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, Carlsson CM, Asthana S, Zetterberg H, Blennow K, Bendlin BB, Rey FE (2017) Gut microbiome alterations in Alzheimer\u2019s disease. Sci Rep 7(1):13537. https:\/\/doi.org\/10.1038\/s41598-017-13601-y","journal-title":"Sci Rep"},{"issue":"1","key":"2433_CR171","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13195-018-0451-2","volume":"10","author":"NM Vogt","year":"2018","unstructured":"Vogt NM, Romano KA, Darst BF, Engelman CD, Johnson SC, Carlsson CM, Asthana S, Blennow K, Zetterberg H, Bendlin BB (2018) The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer\u2019s disease. Alzheimers Res Ther 10(1):124","journal-title":"Alzheimers Res Ther"},{"key":"2433_CR174","unstructured":"Wang R (2022) Disease association study using tensor decomposition and machine learning methods. The Chinese University of Hong Kong (Hong Kong)]"},{"issue":"5","key":"2433_CR172","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1177\/1535370213493069","volume":"238","author":"CH Wang","year":"2013","unstructured":"Wang CH, Wu SB, Wu YT, Wei YH (2013) Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging. Exp Biol Med (Maywood) 238(5):450\u2013460. https:\/\/doi.org\/10.1177\/1535370213493069","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"2433_CR173","doi-asserted-by":"publisher","first-page":"e70062","DOI":"10.1002\/alz.70062","volume":"21","author":"H Wang","year":"2025","unstructured":"Wang H, Serap Monkul Nery E, Ardayfio P, Khanna R, Otero Svaldi D, Gueorguieva I, Shcherbinin S, Andersen SW, Hauck PM, Engle SE, Brooks DA, Collins EC, Fox NC, Greenberg SM, Salloway S, Mintun MA, Sims JR (2025) Modified titration of donanemab reduces ARIA risk and maintains amyloid reduction. Alzheimers Dement 21(4):e70062. https:\/\/doi.org\/10.1002\/alz.70062","journal-title":"Alzheimers Dement"},{"issue":"6","key":"2433_CR175","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1080\/08820139.2026.2669375","volume":"55","author":"S Wang","year":"2026","unstructured":"Wang S, Yuan X, Wang T, Yang M, Dong P, Han H (2026) Mechanisms and therapeutic targeting of the gut microbiota-immune-brain axis in Alzheimer\u2019s disease. Immunol Invest 55(6):1296\u20131326. https:\/\/doi.org\/10.1080\/08820139.2026.2669375","journal-title":"Immunol Invest"},{"issue":"1","key":"2433_CR176","doi-asserted-by":"publisher","first-page":"7924199","DOI":"10.1155\/2022\/7924199","volume":"2022","author":"L Wu","year":"2022","unstructured":"Wu L, Xian X, Xu G, Tan Z, Dong F, Zhang M, Zhang F (2022) Toll-like receptor 4: A promising therapeutic target for Alzheimer\u2019s disease. Mediators Inflamm 2022(1):7924199. https:\/\/doi.org\/10.1155\/2022\/7924199","journal-title":"Mediators Inflamm"},{"key":"2433_CR177","doi-asserted-by":"publisher","first-page":"591429","DOI":"10.2147\/NDT.S591429","volume":"22","author":"T Wu","year":"2026","unstructured":"Wu T, Xing H, Wu T, Xie X, Ji L, Wang W, Zhang X, Zhang Y, Jiang C, Bao T (2026) Imbalance of the brain-gut-microbiota axis in major depressive disorder: from pathogenesis to clinical translation. Neuropsychiatr Dis Treat 22:591429. https:\/\/doi.org\/10.2147\/NDT.S591429","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2433_CR178","doi-asserted-by":"publisher","first-page":"730036","DOI":"10.3389\/fnagi.2022.730036","volume":"14","author":"S Xiang","year":"2022","unstructured":"Xiang S, Ji JL, Li S, Cao XP, Xu W, Tan L, Tan CC (2022) Efficacy and Safety of probiotics for the treatment of Alzheimer\u2019s disease, mild cognitive impairment, and Parkinson\u2019s disease: a systematic review and meta-analysis. Front Aging Neurosci 14:730036. https:\/\/doi.org\/10.3389\/fnagi.2022.730036","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"2433_CR179","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00204-023-03660-8","volume":"98","author":"Y Xiang","year":"2024","unstructured":"Xiang Y, Song X, Long D (2024) Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases. Arch Toxicol 98(3):579\u2013615","journal-title":"Arch Toxicol"},{"issue":"1","key":"2433_CR180","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3233\/JAD-200488","volume":"77","author":"J Xiao","year":"2020","unstructured":"Xiao J, Katsumata N, Bernier F, Ohno K, Yamauchi Y, Odamaki T, Yoshikawa K, Ito K, Kaneko T (2020) Probiotic bifidobacterium breve in improving cognitive functions of older adults with suspected mild cognitive impairment: a randomized, double-blind, placebo-controlled trial. J Alzheimers Dis 77(1):139\u2013147. https:\/\/doi.org\/10.3233\/JAD-200488","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"2433_CR181","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13195-021-00795-7","volume":"13","author":"S Xiao","year":"2021","unstructured":"Xiao S, Chan P, Wang T, Hong Z, Wang S, Kuang W, He J, Pan X, Zhou Y, Ji Y, Wang L, Cheng Y, Peng Y, Ye Q, Wang X, Wu Y, Qu Q, Chen S, Li S, Zhang Z (2021) A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer\u2019s dementia. Alzheimers Res Ther 13(1):62. https:\/\/doi.org\/10.1186\/s13195-021-00795-7","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"2433_CR182","doi-asserted-by":"publisher","first-page":"2501193","DOI":"10.1080\/19490976.2025.2501193","volume":"17","author":"J Xie","year":"2025","unstructured":"Xie J, Van Hoecke L, Van Wonterghem E, Van Imschoot G, Andries V, Vereecke L, Vandenbroucke RE (2025) The gut\u2013brain axis in Alzheimer\u2019s disease is shaped by commensal gut microbiota derived extracellular vesicles. Gut Microbes 17(1):2501193","journal-title":"Gut Microbes"},{"key":"2433_CR183","doi-asserted-by":"publisher","first-page":"1334887","DOI":"10.3389\/fnagi.2024.1334887","volume":"16","author":"L Yan","year":"2024","unstructured":"Yan L, Li H, Qian Y, Zhang J, Cong S, Zhang X, Wu L, Wang Y, Wang M, Yu T (2024) Transcutaneous vagus nerve stimulation: a new strategy for Alzheimer\u2019s disease intervention through the brain-gut-microbiota axis? Front Aging Neurosci 16:1334887","journal-title":"Front Aging Neurosci"},{"key":"2433_CR184","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3389\/fimmu.2020.00724","volume":"11","author":"J Yang","year":"2020","unstructured":"Yang J, Wise L, Fukuchi KI (2020) TLR4 cross-talk with NLRP3 inflammasome and complement signaling pathways in Alzheimer\u2019s disease. Front Immunol 11:724. https:\/\/doi.org\/10.3389\/fimmu.2020.00724","journal-title":"Front Immunol"},{"issue":"27","key":"2433_CR185","doi-asserted-by":"publisher","first-page":"30557","DOI":"10.1021\/acsami.2c06283","volume":"14","author":"L Yang","year":"2022","unstructured":"Yang L, Cui Y, Liang H, Li Z, Wang N, Wang Y, Zheng G (2022) Multifunctional selenium nanoparticles with different surface modifications ameliorate neuroinflammation through the gut microbiota-NLRP3 inflammasome-brain axis in APP\/PS1 mice. ACS Appl Mater Interfaces 14(27):30557\u201330570","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"2433_CR186","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1186\/s12967-025-07209-4","volume":"23","author":"W Zhang","year":"2025","unstructured":"Zhang W, Song J, Zhong F, Yu W, Qin Z, Yang Z, Liu J, Wang X, Chen L, Lu W, Xing D, Liu J, Huang C, Wu J, Liu X, Yu W, Lu Y (2025) Computerized cognitive training enhances cognitive function in Alzheimer\u2019s disease by downregulating Ruminococcus-TMAO pathway. J Transl Med 23(1):1173. https:\/\/doi.org\/10.1186\/s12967-025-07209-4","journal-title":"J Transl Med"},{"issue":"1","key":"2433_CR187","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/13872877261430002","volume":"111","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Zhang D, Xiao H (2026) Regulated neuronal death in Alzheimer\u2019s disease: crosstalk and convergence of apoptosis, pyroptosis, senescence, and ferroptosis. J Alzheimers Dis 111(1):32\u201355. https:\/\/doi.org\/10.1177\/13872877261430002","journal-title":"J Alzheimers Dis"},{"issue":"20","key":"2433_CR190","doi-asserted-by":"publisher","first-page":"12671","DOI":"10.3390\/ijms232012671","volume":"23","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Jaber VR, Pogue AI, Sharfman NM, Taylor C, Lukiw WJ (2022) Lipopolysaccharides (LPSs) as potent neurotoxic glycolipids in Alzheimer\u2019s disease (AD). Int J Mol Sci 23(20):12671","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2433_CR189","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.14283\/jpad.2024.113","volume":"11","author":"Q Zhao","year":"2024","unstructured":"Zhao Q, Baranova A, Cao H, Zhang F (2024) Evaluating causal effects of gut microbiome on Alzheimer\u2019s disease. J Prev Alzheimers Dis 11(6):1843\u20131848. https:\/\/doi.org\/10.14283\/jpad.2024.113","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"2433_CR188","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1186\/s12967-025-07176-w","volume":"23","author":"H Zhao","year":"2025","unstructured":"Zhao H, Tao L, Tang C, Cai W, Shen W (2025) Do immune system and microbiome\u2013gut\u2013brain axis interactions associate with major depressive disorder? J Transl Med 23(1):1279","journal-title":"J Translational Med"},{"issue":"5","key":"2433_CR191","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3892\/ijmm.2023.5314","volume":"52","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Zhang X, Zhang R, Wang Z, Gan J, Gao Q, Yang L, Xu P, Jiang X (2023) Inflammatory signaling pathways in the treatment of Alzheimer\u2019s disease with inhibitors, natural products and metabolites (Review). Int J Mol Med 52(5):111. https:\/\/doi.org\/10.3892\/ijmm.2023.5314","journal-title":"Int J Mol Med"},{"issue":"5","key":"2433_CR192","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s11064-019-02748-x","volume":"44","author":"J Zhou","year":"2019","unstructured":"Zhou J, Yu W, Zhang M, Tian X, Li Y, L\u00fc Y (2019) Imbalance of microglial TLR4\/TREM2 in LPS-treated APP\/PS1 transgenic mice: a potential link between Alzheimer\u2019s disease and systemic inflammation. Neurochem Res 44(5):1138\u20131151","journal-title":"Neurochem Res"},{"key":"2433_CR193","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.bbi.2025.06.011","volume":"129","author":"K Zhou","year":"2025","unstructured":"Zhou K, Wang Y, Xu Y, Zhang Y, Zhu C (2025) Exploring microglial replacement: from disease models to clinical translation. Brain Behav Immun 129:179\u2013185. https:\/\/doi.org\/10.1016\/j.bbi.2025.06.011","journal-title":"Brain Behav Immun"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02433-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02433-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02433-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:02:55Z","timestamp":1792717375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02433-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":191,"alternative-id":["2433"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02433-w","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"16 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ChatGPT (OpenAI) was used during the preparation of this manuscript to assist with grammatical refinement, improvement of language clarity and writing flow, and the preparation and refinement of scientific illustrations. The authors critically reviewed all AI-assisted material and independently edited and finalized the manuscript and illustrations. The authors verified the accuracy, relevance, and scientific integrity of the final content and take full responsibility for the content, interpretations, conclusions, and overall integrity of the published work.","order":5,"name":"Ethics","label":"Declaration of Use of Artificial Intelligence Tools","group":{"name":"EthicsHeading","label":"Declarations"}}]}}